1. Home
  2. PRVA vs FTRE Comparison

PRVA vs FTRE Comparison

Compare PRVA & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRVA
  • FTRE
  • Stock Information
  • Founded
  • PRVA 2007
  • FTRE 1996
  • Country
  • PRVA United States
  • FTRE United States
  • Employees
  • PRVA N/A
  • FTRE N/A
  • Industry
  • PRVA Retail: Computer Software & Peripheral Equipment
  • FTRE Medical Specialities
  • Sector
  • PRVA Technology
  • FTRE Health Care
  • Exchange
  • PRVA Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • PRVA 2.3B
  • FTRE 1.9B
  • IPO Year
  • PRVA 2021
  • FTRE N/A
  • Fundamental
  • Price
  • PRVA $22.73
  • FTRE $18.70
  • Analyst Decision
  • PRVA Strong Buy
  • FTRE Hold
  • Analyst Count
  • PRVA 16
  • FTRE 11
  • Target Price
  • PRVA $24.63
  • FTRE $23.30
  • AVG Volume (30 Days)
  • PRVA 628.4K
  • FTRE 890.4K
  • Earning Date
  • PRVA 02-25-2025
  • FTRE 03-10-2025
  • Dividend Yield
  • PRVA N/A
  • FTRE N/A
  • EPS Growth
  • PRVA N/A
  • FTRE N/A
  • EPS
  • PRVA 0.11
  • FTRE N/A
  • Revenue
  • PRVA $1,716,318,000.00
  • FTRE $2,975,600,000.00
  • Revenue This Year
  • PRVA $78.50
  • FTRE N/A
  • Revenue Next Year
  • PRVA $11.52
  • FTRE $1.09
  • P/E Ratio
  • PRVA $212.13
  • FTRE N/A
  • Revenue Growth
  • PRVA 8.54
  • FTRE 2.80
  • 52 Week Low
  • PRVA $15.92
  • FTRE $16.53
  • 52 Week High
  • PRVA $23.24
  • FTRE $41.02
  • Technical
  • Relative Strength Index (RSI)
  • PRVA 69.75
  • FTRE 48.38
  • Support Level
  • PRVA $19.74
  • FTRE $16.94
  • Resistance Level
  • PRVA $21.48
  • FTRE $18.52
  • Average True Range (ATR)
  • PRVA 0.77
  • FTRE 1.00
  • MACD
  • PRVA 0.29
  • FTRE -0.02
  • Stochastic Oscillator
  • PRVA 90.84
  • FTRE 53.01

About PRVA Privia Health Group Inc.

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: